Drugmakers Pledge to Cooperate with Oversight Committee’s Drug Pricing Investigation

Drug Industry Daily
A A
Drugmakers are pushing back against claims by newly-seated House Oversight Committee Chair Elijah Cummings (D-Md.) about their drug pricing practices, but say they will cooperate with the committee’s investigation.

To View This Article:

Login

Subscribe To Drug Industry Daily